Viruses that establish persistent infections have evolved numerous strategies to evade host innate antiviral responses. We functionally assessed the role of herpes simplex virus type 2 (HSV-2) virion host shutoff (vhs) protein on innate immune sensing pathways in human vaginal epithelial cells (VK2 ECs). Infection of cells with wild-type (WT) HSV-2 significantly decreased expression of innate immune sensors of viral infection, Toll-like receptor (TLR)2, TLR3, retinoic acid inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (Mda-5), relative to cells infected with a mutant that lacks vhs (vhsB) or mock-infected cells. Transfection with HSV-2 vhs similarly decreased expression of TLR2, TLR3, RIG-I and Mda-5, which was also confirmed in human embryonic kidney (HEK) 293 cells. vhsB infection of VK2 cells caused robust increases in the active form of interferon regulatory factor (IRF)3 and its translocation to the nucleus compared with the WT. Additionally, IRF3 activation by Sendai virus and polyinosinic : polycytidylic acidinduced stimulation of beta interferon (IFN-b) was significantly inhibited in vhs-transfected cells. Overall, our findings provide the first evidence that HSV-2 vhs plays roles in selectively inhibiting TLR3 and RIG-I/Mda-5, as well as TLR2-mediated antiviral pathways for sensing dsRNA and effectively suppresses IFN-b antiviral responses in human vaginal ECs.
INTRODUCTION
Viruses that establish chronic persistent infections have evolved complex and efficient mechanisms to overcome host innate and adaptive immune responses (Finlay & McFadden, 2006) . Toll-like receptors (TLRs) are among the earliest sensors of infection and there is growing interest in characterizing strategies used by viruses to evade either innate recognition or downstream signalling pathways that alert cells to viral infection (Finberg et al., 2007; Pichlmair & Reis e Sousa, 2007; Takeuchi & Akira, 2007; Thompson & Locarnini, 2007) .
Herpes simplex virus type 2 (HSV-2) is a major sexually transmitted pathogen causing genital tract infection. One of the key early events during the replication cycle of HSV is the shutoff of host macromolecular synthesis. The alphaherpesvirus family conserves the UL41 gene, which encodes the virion host shutoff (vhs) protein that is packaged in the virion tegument. Following viral entry into cells, vhs is released and uses its RNase activity to degrade pre-existing and newly transcribed mRNA including its own mRNA for rapid transition of infectious phases rather than rRNA or tRNA (Kwong & Frenkel, 1987) . However, vhs does not generally induce complete blockage of cellular protein synthesis and is not overtly toxic (Smiley, 2004) . Some inducible mRNAs showed no degradation (Taddeo et al., 2003) .
HSV-2 vhs is~40-fold more active than that of HSV-1 (Everly & Read, 1997) . In vivo studies in mice using mutant HSV-2 that lacks vhs (vhsB) (Smith et al., 2002) showed the biological roles of vhs in virulence, including suppression of proinflammatory chemokines and cytokines, loss of major histocompatibility complex (MHC) class I/MHC class II facilitating resistance to lysis of infected cells by cytotoxic T lymphocytes, and quenching activation of some antigen-presenting dendritic cell (DC) subtypes (Samady et al., 2003; Smith et al., 2002; Suzutani et al., 2000; Tigges et al., 1996) . Non-enzymically active vhs protein interferes with efficient virus replication and plays a complex role in vhs-mediated type I interferon (IFN) resistance (Korom et al., 2008) . Recently, replacement of HSV-2 vhs with HSV-1 vhs in a HSV-2 vaccine candidate, dl5-29-41.1 virus, showed increased immunogenicity and protection against HSV-2 challenge in the murine model of infection with higher titres than the parental strain (Reszka et al., 2010) . Together these findings suggest that vhs may help HSV-2 in evasion of host innate and adaptive responses.
The genital mucosa is the first line of defence to prevent HSV-2 from establishing persistent infection. Triggering of innate antiviral responses depends on recognition of viral components, such as nucleic acids, by host patternrecognition receptors that include TLRs and retinoic acid inducible gene I (RIG-I)-like receptors (RLR). These two classes of innate receptors are expressed in different intracellular compartments and induce type I IFN via distinct signalling pathways. Previously, we showed that TLR3 is expressed in murine vaginal epithelium isolated using laser capture microdissection and its expression was significantly increased during natural dioestrus and following treatment with the long acting progestin, Depo-Provera (Yao et al., 2007) . Local intravaginal delivery of polyinosinic : polycytidylic acid (polyIC) protected female mice against genital HSV-2 infection (Ashkar et al., 2004) and correlated with beta interferon (IFN-b) production (Gill et al., 2006) . Epithelial cells (ECs) of the human fallopian tube highly express TLR3 and responded to dsRNA with secretion of interleukin (IL)-6 and IL-8 against virus infection (Nasu et al., 2007) . Cervical mucosal epithelium expresses functional TLR3 and TLR9 to regulate the proinflammatory cytokine and antiviral environment in the lower female reproductive tract (Andersen et al., 2006) . Patients with TLR3 deficiency are susceptible to HSV-1 encephalitis, which is probably due to impaired TLR3-dependent type I IFN responses (Zhang et al., 2007) . Innate recognition of herpes viruses occurs via TLR3 as well as TLR9 and TLR2. DCs were shown to recognize viral genomic dsDNA via TLR9 in both HSV-1 (Krug et al., 2004; Lund et al., 2003) and HSV-2 (Lund et al., 2003) . Recently, TLR2 was identified to join the IFN gang in the subset of inflammatory monocytes in response to viral infection (Barbalat et al., 2009; Bauernfeind & Hornung, 2009) . Using knockout mouse models, Kurt-Jones et al. (2004) demonstrated that TLR2 was associated with inflammatory cytokine responses and lethal HSV-1 encephalitis and subsequently went on to show that TLR2 on macrophages may be responsible for the sepsis syndrome seen in HSV-1 and HSV-2 infection of neonates (Kurt-Jones et al., 2005) . Polymorphisms in TLR2 were shown to be associated with increased shedding and severity of HSV-2 infection in infected individuals (Bochud et al., 2007) .
Transcription analysis and immunocytochemistry in mucosal specimens show a potent alteration in host defence during HSV-2 infection. HSV-2's blockade of type I IFN production by the innate immune system may be a major factor in allowing the virus to break through host mucosal defences (Peng et al., 2009) . Mechanisms behind this have yet to be further elucidated. The objective of the present study was to functionally assess the role of HSV-2 vhs on innate immune evasion in human genital ECs and determine whether this is related to TLRs for sensing dsRNA or other factors in innate signalling pathways using a combination of infection with a vhs mutant HSV-2 and vhs-transfection experiments.
RESULTS

HSV-2 vhs selectively suppresses expression of innate immune sensors of viral infection
In initial experiments we assessed the role of vhs in affecting the expression profile of TLRs by comparing human vaginal (VK2) ECs infected with wild-type (WT) HSV-2 or vhsB (which lacks functional vhs) to uninfected cells. Infection of VK2 with WT HSV-2 significantly decreased expression of immune sensors of viral infection, TLR2, TLR3, RIG-I and melanoma differentiation-associated gene 5 (Mda-5), relative to mock-or vhsB-infected cells at both the mRNA (Fig. 1a ) and the protein (Fig. 1b) levels. However, infection with vhsB significantly increased TLR9 expression in both mRNA and protein levels, while WT HSV-2 did not affect expression of TLR9 in the cells (Fig. 1a, b) .
Once cells are infected with HSV-2, multiple viral proteins [e.g. infected cell polypeptide (ICP)0 and ICP27] contribute to viral host immune evasion (Fakioglu et al., 2008; Melchjorsen et al., 2006) . Therefore, in order to clearly assess the role of vhs in innate immune evasion, we constructed an HSV-2 vhs gene expression plasmid, pUL41, and transiently expressed vhs in VK2 ECs as well as in human embryonic kidney (HEK) 293 cells (Fig. 2a) . As the detection controls, in viral infected cells vhs was displayed in a low amount at 3 h post-infection (p.i.) and highly expressed at late times of infection. The amount of vhs expressed was markedly lower in pUL41-transfected cells compared with infected cells. This was probably due to the low transfection frequency (approximately 20-30 %) of VK2 cells. Furthermore, we evaluated the cellular viability in cells transfected with pUL41 (Fig. 2b) . Although about 50 % nucleofector-treated cells survived, cells transfected with pUL41 showed similar viability to vector pcDNA-transfected cells in both plasmid alone and plasmid/polyIC co-transfected cells. Viability of HEK 293 cells was not affected by transfecting both plasmids in the presence or the absence of polyIC (Fig. 2b) .
Next in transfection experiments, significantly decreased expression of TLR3 mRNA and protein was observed following co-transfection of pUL41 with and without polyIC, compared with the pcDNA transfected controls (Fig. 3a, b) . Expression of TLR2 also showed an approximately twofold suppression in vhs-expressing cells under the same conditions. Together, our infection ( Fig. 1 ) and vhs transfection data show the selective action of vhs protein in diminishing expression of host TLR2 and TLR3. However, expression of other TLRs (e.g. TLR9) was not affected by vhs (Fig. 3a, b ).
Since the above data indicated that vhs targeted TLR3, we also measured expression of the cytosolic dsRNA receptors, RIG-I and Mda-5, in HSV-2 WT-and vhsB-infected and transfected cells. Results in Fig. 1 showed that infection of VK2 cells with WT HSV-2 significantly inhibited expression of RIG-I and Mda-5 at both mRNA and protein levels, whereas infection with vhsB profoundly increased expression of these two innate cytosolic dsRNA sensors compared with WT HSV-2 and mock infection. pUL41-transfected cells displayed significantly lower levels of RIG-I and Mda-5 mRNA (Fig. 3a) and protein ( Fig. 3b ) compared with the controls. Furthermore, co-transfection of polyIC upregulated mRNA expression of both RIG-I and Mda-5 about twofold higher in vector-transfected cells than in pUL41-transfected cells. Indeed, increased expression of RIG-I and Mda-5 following transfection, as well as polyIC induction of these receptors, was significantly inhibited by vhs. We also confirmed these findings in another human EC line, HEK 293 cells, transfected with pUL41 ( Fig. 3c, d ). Besides targeting TLR2 expression, these results show that vhs is capable of selectively suppressing expression of innate receptors for dsRNA sensing pathways, TLR3, RIG-I and Mda-5, while not targeting TLR7, TLR8 (results not shown) and TLR9.
HSV-2 vhs blocks interferon regulatory factor (IRF3) activation and translocation to the nucleus of genital ECs
Since expression of innate sensors of dsRNA was affected by vhs, we next investigated whether downstream innate signalling components were targeted by viral vhs. Expression of the TLR3 adaptor protein, TRIF (TIRdomain-containing adaptor-inducing IFN-b), and the level of TBK1 (TANK-binding kinase) protein, one of the IRF3 kinases, was detected at comparable levels in cells infected with HSV-2 WT or vhsB (data not shown).
IRF3 plays a key role in response to viral infection and is necessary for the transcriptional induction of type I IFN genes (Sato et al., 2000) . Under the same experimental conditions described above, the active form of IRF3 protein was detected using native PAGE followed by Western blot analysis. Our results (Fig. 4a) showed that in VK2 cells infected with HSV-2 vhsB the IRF3 dimer was clearly observed, appearing 2 h p.i. and accumulating by 8 h p.i., compared with cells infected with the same m.o.i. of WT HSV-2. We also consistently observed the translocation of IRF3 into the nuclei of the cells infected with vhsB, which did not occur in mock-infected cells and was markedly reduced in WT virus-infected cells (Fig. 4b) . These results suggest that viral vhs may be involved in inactivation of IRF3.
Further, we transiently overexpressed HSV-2 vhs in cells by transfecting pUL41. Subsequently, Sendai virus (SeV), a potent inducer of IRF3, was used to challenge the plasmidtransfected cells. Results demonstrated that the IRF3 dimer stimulated by SeV was markedly reduced in the cells expressing vhs [ Fig. 5a (ii), lane 4 versus lane 3]. The level of IRF3 monomeric protein was constant under all experimental conditions [ Fig. 5a(i) ] indicating that suppression of IRF3 activation by vhs is not due to degradation of expressed IRF3. Similar results were also found in studies using HEK 293 cells (Fig. 5a ). (4)]. These observations clearly demonstrate that viral vhs protein has the ability to block IRF3 activation and/or translocation into the nuclei of human ECs.
HSV-2 vhs suppresses IFN-b expression and function in human genital ECs
It was previously proposed that HSV-2 infection and replication in ECs may trigger the production of cytokines and type I IFN (Duerst & Morrison, 2004) . Next, we examined the effect of in vitro infection of human genital ECs with HSV-2 WT versus vhsB on IFN-b expression. Our results (Fig. 6a) showed that IFN-b mRNA production was significantly increased in VK2 cells following virus infection (P,0.0001 in one-way ANOVA analysis), with 17.5-fold increase after infection with HSV-2 vhsB compared with mock infection. In contrast, there was only a 3.8-fold increase in IFN-b mRNA expression following infection with WT HSV-2 (Fig. 6a) . To our surprise, despite these significant increases in IFN-b mRNA, IFN-b protein was undetectable in cells from 6 to 20 h p.i. using ELISA (data not shown). However, one of IFN-b's activities, namely upregulation of IFN-stimulated gene (ISG)56 expression was assessed in cells infected with HSV-2 WT or vhsB at 7 h p.i. ISG56 mRNA expression was inhibited in cells infected with WT virus, but ISG56 mRNA was markedly increased over levels in uninfected cells following infection with the vhsB mutant (Fig. 6b) . These results suggest that vhs is probably involved in interfering with host innate defences by reducing IFN-b production in human genital ECs.
Subsequently, results shown in Fig. 7(a) demonstrated that IFN-b protein was significantly decreased in VK2 ECs transfected with pUL41 compared with the vector control (P,0.05). Co-transfection of polyIC with either vector or HSV-2 vhs suppresses innate nucleic acid sensing in ECs pUL41 strongly stimulated IFN-b protein expression, but in the presence of pUL41 also showed significantly less IFN-b induction than vector control (P,0.05) (Fig. 7a) . Expression of IFN-b mRNA showed a similar pattern to protein expression (Fig. 7b) . However, the mRNA data were not statistically significant in VK2 cells, suggesting that HSV-2 vhs may not directly target IFN-b mRNA. Expression of IFN-b was strongly inhibited by transfecting pUL41 in HEK 293 cells (Fig. 7a, b) . Furthermore, expression of ISG56 was correspondingly suppressed in cells overexpressing vhs versus the vector-transfected control (Fig. 7c) . This provides further evidence that IFN-b protein and function were suppressed by vhs. Nevertheless, polyIC did not induce high ISG56 expression, responding to higher IFN-b levels under the same experimental conditions. IFN-b stimulation by vhsB infection correlates with IRF3 rather than nuclear factor kappa B (NF-
kB)
In order to examine whether IRF3 is responsible for the stimulation of IFN-b by vhsB, gene silencing experiments were performed using small interfering RNA (siRNA). Following treatment of VK2 cells with IRF3 siRNA624 for 3 days, the cells were infected with either HSV-2 WT or vhsB for 7 h. Western blot analysis showed that IRF3 monomer expression was knocked down and IRF3 dimer almost totally disappeared after siRNA treatment (Fig. 8a) . Under these conditions IFN-b mRNA stimulated by vhsB in IRF3 knockdown cells was significantly (P,0.05) reduced to the level seen in cells infected with WT virus (Fig. 8b) . In other words, knockdown of IRF3 expression suppressed the stimulation of IFN-b by vhsB virus.
Considering that NF-kB is one part of the IFN-b enhanceasome and is frequently targeted by other virus evasion strategies, we measured NF-kB activation by detection of the p65 NF-kB subunit in the nuclei of cells infected with HSV-2 WT and vhsB. Results in Supplementary Fig. S1 (available in JGV Online) show that p65 protein accumulated in both HSV-2 WT-and vhsB-infected nuclei to similar extents and was comparable to TLR2 stimulation with Pam3CSK positive control, indicating that vhs does not affect NF-kB activation. Expression of IL-6 mRNA also displayed the same pattern as NF-kB (data not shown), which participates in upregulation of the IL-6 promoter during both HSV-1 and HSV-2 infection (Paludan, 2001 ). Together, these results suggest that IFN-b stimulation by HSV-2 vhs mutant correlated with IRF3 rather than NF-kB.
DISCUSSION
Our results demonstrate the specificity of HSV-2 vhs for different mRNAs since vhs strongly inhibited TLR2, TLR3 and RIG-I/Mda-5 in vaginal ECs but not other TLRs. This finding suggests that evasion of these innate sensors, X.-D. Yao and K. L. Rosenthal especially those involved with sensing dsRNA, may be critical for HSV-2 to establish early infection in the host. Downstream of Toll-signalling pathways the levels of IRF3, TBK1 and TRIF proteins, and NF-kB activity were not influenced by vhs in vaginal ECs. It is known that HSV vhs collaborates with ICP27 to reduce the abundance of host mRNA during infection (Hardwicke & Sandri-Goldin, 1994; Song et al., 2001) . The RNase-dependent vhs exhibits a high degree of functional specificity in vivo, as it apparently targets only mRNAs and spares other cytoplasmic RNA through interactions with one or more cellular translation initiation factors, such as eIF4H and eIF4Hb (Doepker et al., 2004; Feng et al., 2005; Sarma et al., 2008; Taddeo et al., 2006) . Although the mechanism of suppression of the dsRNA sensors by vhs is not fully understood, we propose that the end effect of vhs on these mRNA may be the net result of a cascade of downstream effects on expression of numerous genes. These comprehensive effects generated by vhs help HSV-2 evade host antiviral defences, particularly in blocking dsRNA-sensing pathways. In this study, we also found that TLR9 expression in vhsB-infected cells was significantly increased 
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compared with WT HSV-2 (Fig. 1) . Our observations are consistent with the speculation that vhs selectively impairs the expression of a small subset of key cellular genes involved in host innate antiviral responses (Smiley, 2004) .
Compared with the WT, infection of vaginal ECs with vhsB significantly increased expression of the active form of IRF3 and its translocation to the nucleus. Although expression of IFN-b mRNA was significantly increased in human vaginal ECs infected with WT HSV-2, it was more profoundly enhanced by vhsB (Fig. 6) . However, ISG56, a type I IFN-stimulated gene, was strongly expressed in vhsBinfected cells but not in WT HSV-2-infected cells, suggesting that expression of this gene might be targeted by vhs both via direct degradation and indirectly through restricted production of active IRF3 and IFN-b. It is known that ISG56 is an IRF3-dependent gene (Elco et al., 2005) , which contains an IFN-stimulated response element (ISRE) in the promoter region bound by IRF3/p300 (Weaver et al., 1998) . ISG56 is strongly induced in response to IFN, dsRNA and infection by many viruses (Guo et al., 2000) . It is noteworthy that IFN-b protein was undetectable following HSV-2 infection, although one of its functions, notably stimulating ISG56, was observed. Other mechanisms might exist for blocking translation of IFN-b mRNA.
Further, IFN-b stimulation by HSV-2 vhsB correlated with activation of IRF3 rather than NF-kB. While our results may be strengthened through using revertant viruses, we currently do not have access to them. Our data are supported by the observations in transfection experiments using multiple cell lines. IFN-b expression was significantly reduced in ECs transfected with pUL41 in both the absence and the presence of polyIC, compared with vector control. Overexpression of vhs in ECs significantly inhibited activation of IRF3 by SeV. Additionally, studies concerned with the localization of IRF3 using IRF3-GFP showed that vhs blocked IRF3 translocation into the nuclei of ECs stimulated with SeV. IRF3 is a potent activator of IFN-b. However, siRNA knockdown of IRF3 only partially suppressed IFN-b production induced by HSV-2 vhsB. It is possible that remaining trace amounts of IRF3 following knockdown may still play a crucial role in stimulating IFN production in response to virus infection. Alternatively, other IRFs, such as IRF7, might compensate for stimulation of IFN-b transcription during virus infection when IRF3 is disabled. Indeed, in IRF3/IRF7 double knockout mice, IFN-b levels were completely abrogated (Honda et al., 2005) . Type I IFN mRNA was also still expressed after stimulation of DCs from Irf3 2/2 mice with polyIC, and this residual induction was abolished in DCs lacking both IRF3 and IRF7. Therefore IRF7 is also required for complete induction of type I IFN genes during TRIFmediated signalling (Honda & Taniguchi, 2006) . This presumption is also indirectly supported by our studies using IRF3 knockout mouse embryo fibroblasts (MEFs Irf3
2/2
). We found that IFN-b was increased about threefold in Irf3 2/2 MEFs with both WT HSV-2 and vhsB, while in MEFs IFN-b was increased roughly ninefold with HSV-2 WT and 29-fold with vhsB, respectively (data not shown). These findings indicate that IRF3 is the major IFN regulator targeted by HSV-2 vhs protein in fibroblasts, but not the only one to enhance IFN-b production during HSV infection. Indeed, different cell types are likely to have their own preferred pathways to respond to herpes viruses.
Similarly, it is unclear whether the reduced levels of IFN-b mRNA are caused by either vhs-induced degradation or by reduced synthesis as a consequence of impaired IRF3-dependent signalling. Based on our findings, we propose that HSV-2 vhs protein probably targets three sites of innate immunity to shut down host IFN-b in human vaginal ECs early following infection: (i) targeting TLR2 and the dsRNA receptors, TLR3, RIG-I/Mda-5 to selectively suppress activation of these innate signalling pathways; (ii) blocking IRF3 activation by an unknown mechanism; and (iii) directly degrading IFN-b and IFN-bdependent ISG transcripts. It seems that degradation of IFN-b mRNA is minimally targeted by vhs, since IFN-b mRNA was not significantly suppressed in vhs transiently expressing cells (Fig. 7b) , whereas the protein was significantly inhibited by vhs in the presence and absence of polyIC (Fig. 7a) .
The role of type I IFN signalling in the prevention of genital HSV-2 infection has been explored (Svensson et al., 2007) and many viruses use their own gene products to X.-D. Yao and K. L. Rosenthal disarm the IFN response during productive infection. To date in herpes viruses, it has been shown that bovine ICP0 is able to degrade IRF3 with its zinc RING finger and sequences near to its C terminus (Saira et al., 2007) that cooperate with host p300 (Zhang et al., 2006) . HSV-1 ICP0 blocks IRF3-and IRF7-mediated activation of ISGs and the RING finger domain of ICP0 is essential for this activity (Lin et al., 2004) . ICP0 is necessary for the inhibition of IRF3 nuclear accumulation and reduction of IFN-b. However, ICP0 mutant HSV-1 is still able to inhibit IFNb production induced by SeV infection, indicating that multiple mechanisms exist for blocking IFN-mediated host response (Melroe et al., 2004) . HSV-1 ICP0 inhibits IRF3 when located in the cytoplasm and its RING finger domain is associated with E3 ubiquin activity, which plays a critical role in modulating the cellular location of ICP0 (Paladino et al., 2010) . HSV-1 ICP27 has also been identified as an important viral protein counteracting the early immune response by targeting NF-kB and IRF3 augmented by ICP4 (Melchjorsen et al., 2006) , though ICP27 is controversially reported as a requirement for NF-kB activation (Hargett et al., 2006) . HSV-1 vhs reacts on multiple sites of signalling pathways, at least, in inhibiting STAT1 (member of the Signal Transducers and Activators of Transcription family of transcription factors) activation in IFN-c signalling (Eisemann et al., 2007; Pasieka et al., 2009) , reducing Janus kinase 1 (Jak1) and STAT2 in the Jak/STAT pathway of IFN signalling pathways (Chee & Roizman, 2004) . In addition, HSV-1 vhs inhibits the IFN response by limiting the production of dsRNA derived from the viral genome (Pasieka et al., 2008) . Therefore, it is clear that IFN signalling pathways are so critical for host immunity that HSV has evolved and encodes multiple proteins, including ICP0, ICP4, ICP27 and vhs, to block these pathways during 
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infection. Significantly, this current study also identifies a previously unappreciated and novel function for HSV-2 vhs, notably its manipulation of TLR expression.
Our findings reflect a complex role of vhs in HSV-2 immune evasion. NF-kB has been shown to be activated in response to HSV infection (Patel et al., 1998) and is needed by both the virus and the host. Herpes viruses activate NFkB for productive viral replication and to directly control transcription (Amici et al., 2006) , using a tegument protein UL37 through TRAF6 (Liu et al., 2008) . The transcription factors NF-kB, IRF3 and ATF-2/c-Jun serve as a multiprotein complex called the enhanceosome to regulate type I IFN-b expression. vhs does not target NF-kB, but significantly suppresses TLR3-IRF3 and RIG-I/Mda-5 axes effectively reducing IFN-b, as shown in HSV-1 (Chee & Roizman, 2004) . Most recently it was reported that HSV-1 vhs shows activation of internal ribosome entry sites (IRES)-dependent translation which is uncoupled from the classical shutoff function of vhs (Saffran et al., 2010) . Therefore, these new functions ascribed to vhs during herpes virus infection have begun to be identified and require further elucidation.
In conclusion, the data presented in this paper demonstrate that induction of IFN-b by HSV-2 vhsB in human vaginal ECs is directly related to activation and accumulation of IRF3 in the nucleus. HSV-2 vhs protein selectively inhibits expression of TLR2 and innate dsRNA receptors TLR3 and RIG-I/Mda-5, and prevents IRF3 dimerization and translocation. Thus, the two branches of innate cellular signalling pathways, TLR3-dependent-versus TLR3-independent-IRF3 axes, are both targeted by HSV-2 vhs. Our findings provide additional evidence that HSV-2 gene products occlude the IFN signalling pathways at multiple sites. Given the role of vhs in host gene shutdown, this work contributes to our understanding of innate immune evasion by HSV-2. Utilization of this knowledge will hopefully improve strategies for the development of improved HSV-2 vaccines and antiviral therapy. Transfection. VK2 cells were transfected with either pcDNA or pUL41 using Nucleofector II (Amaxa). Briefly, 1.4610 6 VK2 cells were resuspended in 100 ml Solution L and 2 mg plasmid was added either with or without 0.4 mg polyIC. The cell mixture was shocked using Program D-033. The cells were then cultured for 14-24 h. HEK 293 cells were transfected with plasmids using Lipofectamine 2000 as per the manufacturer's instruction (Invitrogen).
METHODS
QRT-PCR. TRIzol-dissolved RNA from transfected/infected cells was processed as described previously (Lester et al., 2008) . TaqMan primers and probes used here are listed in Supplementary Table S1 P=0. X.-D. Yao and K. L. Rosenthal (available in JGV Online). Relative mRNA expression levels were normalized with 18S rRNA and eventually calibrated to mockinfected or pcDNA-transfected samples.
Conventional RT-PCR. cDNA converted in RT was used with 2 ml in 40 ml PCR containing 1 mM ISG56 (GenBank accession no. NM_001548) forward primer (59-GACAGGAAGCTGAAGGAGAAA-39), 1 mM ISG56 reverse primer (59-TCTTGCATTGTTTCTTCTA-CCACT-39) and SuperMix (Invitrogen) with 30 cycles of 94 uC 20 s, 55 uC 30 s and 72 uC 1 min. Separately, 20 ml of 18S rRNA PCR was set using 0.4 ml of RT, 200 nM 18S rRNA forward primer (59-GCATTCGTATTGCGCCGCTA-39), 200 nM 18S rRNA reverse primer (59-AGCTGCCCGGCGGGTC-39) and SuperMix with the same PCR programme. Then the pooled PCR amplicons of ISG56 and 18S rRNA per sample were loaded in 2 % agarose gel.
Western blot analysis. The transfected or infected cells were lysed with either the native buffer [50 mM Tris/HCl pH 8.0, 150 mM NaCl, 5 mM sodium orthovanadate, 5 mg protease inhibitor cocktail (Roche) ml 21 ] or RIPA, 0.2 % SDS, 5 mg protease inhibitor cocktail ml 21 . The protein concentration was determined using DC Protein Assay (Bio-Rad). Under native as well as reducing conditions 10 mg of protein was electrophoresed and then electro-blotted onto a PVDF membrane (Bio-Rad). The 5 % milk-TBST-blocked membranes were bound, respectively, with anti-human IRF3 (IBL 18781) for native gel-run samples and with other anti-human antibodies [TLR2, TLR3, TLR9 (Imgenex), RIG-I, Mda-5, S6 (Cell Signalling Technologies), IRF3 (sc-9082), Histone H1 (Santa Cruz), anti-GAPDH (Abcam) and anti HSV-2 vhs mouse mAb (provided by Dr David Leib, Washington University)]. Subsequently, either goat anti-rabbit (Santa Cruz) or anti-mouse IgG-conjugated with HRP (Bio-Rad) were used for detection and the membranes were developed with Super Signal West Femto/Pico Chemiluminescent Substrates (Thermo). The protein signals were visualized following exposure to X-ray films (Thermo).
IFN-b ELISA. The culture media harvested from cells, which were either infected with HSV-2 WT or vhsB or transfected with plasmid/ polyIC for various times, were diluted twofold and an ELISA was performed for detecting the concentration of IFN-b protein in a 96-well pre-coated plate as per the manufacturer's instruction (Antigenix).
Confocal and fluorescence microscopy. VK2 cells were infected with WT or vhsB HSV-2 at an m.o.i. of 2.5 p.f.u. per cell for 6 h. After fixation with 4 % paraformaldehyde, permeabilized with 0.1 % Triton X-100 and blocked with 5 % BSA-5 % normal goat serum, the cells were bound with anti-human IRF3 (IBL 18781) and subsequently reacted with goat anti-rabbit IgG-Alexa Fluor 488 (Invitrogen). Finally, the cells were stained with 33.3 mg propidium iodide ml 21 and mounted.
VK2 cells were co-transfected with pIRF3-GFP and pUL41 or pcDNA using Nucleofector II for 14 h and then superinfected with 80 U of SeV for 6 h. After fixing and mounting, GFP localization in the cells was directly observed under a confocal microscope (Carl Zeiss, Axiovert 100M, LSM510). HEK 293 cells were co-transfected with the above plasmids with Lipofectamine 2000 for 24 h and then superinfected with 80 U of SeV for 6 h. GFP location of the fixed HEK 293 cells was monitored under a fluorescence microscope (Leica).
